ClinVar Miner

Submissions for variant NM_001244008.2(KIF1A):c.4812C>A (p.Thr1604=)

gnomAD frequency: 0.00862  dbSNP: rs76974316
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 11
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Genetic Services Laboratory, University of Chicago RCV000117402 SCV000151601 benign not specified 2021-03-01 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000295814 SCV000429186 likely benign Hereditary spastic paraplegia 30 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease.
Labcorp Genetics (formerly Invitae), Labcorp RCV000551948 SCV000638624 benign Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intellectual disability, autosomal dominant 9 2024-01-30 criteria provided, single submitter clinical testing
Ambry Genetics RCV002313902 SCV000847353 benign Inborn genetic diseases 2016-05-14 criteria provided, single submitter clinical testing This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV001610412 SCV001477886 benign not provided 2023-08-21 criteria provided, single submitter clinical testing
GeneDx RCV001610412 SCV001837130 benign not provided 2015-03-03 criteria provided, single submitter clinical testing
Genome Diagnostics Laboratory, The Hospital for Sick Children RCV001847703 SCV002105250 benign Hereditary spastic paraplegia 2021-02-22 criteria provided, single submitter clinical testing
Breakthrough Genomics, Breakthrough Genomics RCV001610412 SCV005261913 likely benign not provided criteria provided, single submitter not provided
Clinical Genetics, Academic Medical Center RCV001610412 SCV001919875 likely benign not provided no assertion criteria provided clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV000117402 SCV001952037 benign not specified no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000117402 SCV001973228 benign not specified no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.